{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T10:26:28Z","timestamp":1747218388386,"version":"3.40.5"},"reference-count":19,"publisher":"Aboutscience Srl","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Grhta"],"abstract":"<jats:p>Introduction: Chimeric antigen receptor (CAR) T-cell therapies are novel immunotherapies for the treatment of hematologic malignancies. They are administered in specialized centers by a multidisciplinary team and require the careful coordination of all steps involved in manufacturing and using cellular therapies. The Maturity Model (MM) is a tool developed and used for assessing the effectiveness of a variety of activities. In healthcare, it may assist clinicians in the gradual improvement of patient management with CAR T-cell therapy and other complex treatments.\nMethods: The START CAR-T project was initiated to investigate the potential of a MM in the setting of CAR T-cell therapy. Four Italian clinics participated in the creation of a dedicated MM. Following the development and test of this MM, its validity and generalizability were further tested with a questionnaire submitted to 18 Italian centers.\nResults: The START CAR-T MM assessed the maturity level of clinical sites, with a focus on organization, process, and digital support. For each area, the model defined four maturity steps, and indicated the actions required to evolve from a basic to an advanced status. The application of the MM to 18 clinical sites provided a description of the maturity level of Italian centers with regard to the introduction of CAR T-cell therapy.\nConclusion: The START CAR-T MM appears to be a useful and widely applicable tool. It may help centers optimize many aspects of CAR T-cell therapy and improve patient access to this novel treatment option.<\/jats:p>","DOI":"10.33393\/grhta.2022.2340","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T10:43:04Z","timestamp":1641811384000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Use of a maturity model for facilitating the introduction of CAR T-cell therapy\u2014Results of the START CAR-T project"],"prefix":"10.33393","volume":"9","author":[{"given":"Stefania","family":"Bramanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-4839","authenticated-orcid":false,"given":"Matteo","family":"Carrabba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Di Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-6237","authenticated-orcid":false,"given":"Elena","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-8423","authenticated-orcid":false,"given":"Luca","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Tisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18642","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"5219","doi-asserted-by":"crossref","unstructured":"Katz B-Z, Herishanu Y. Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond. Leuk Lymphoma. 2014;55(5):999-1006. https:\/\/doi.org\/10.3109\/10428194.2013.828354 PMID:23885836","DOI":"10.3109\/10428194.2013.828354"},{"key":"5220","doi-asserted-by":"crossref","unstructured":"Greenbaum U, Mahadeo KM, Kebriaei P, Shpall EJ, Saini NY. Chimeric antigen receptor T-cells in B-acute lymphoblastic leukemia: state of the art and future directions. Front Oncol. 2020;10:1594. https:\/\/doi.org\/10.3389\/fonc.2020.01594 PMID:32984022","DOI":"10.3389\/fonc.2020.01594"},{"key":"5221","doi-asserted-by":"crossref","unstructured":"Elsallab M, Levine BL, Wayne AS, Abou-El-Enein M. CAR T-cell product performance in haematological malignancies before and after marketing authorisation. Lancet Oncol. 2020;21(2):e104-e116. https:\/\/doi.org\/10.1016\/S1470-2045(19)30729-6 PMID:32007196","DOI":"10.1016\/S1470-2045(19)30729-6"},{"key":"5222","doi-asserted-by":"crossref","unstructured":"Gotti M, Defrancesco I, D\u2019Angelo M, et al. Cancer Immunotherapy using chimeric antigen receptor expressing T-cells: present and future needs of clinical cancer centers. Front Immunol. 2020;11:565236. https:\/\/doi.org\/10.3389\/fimmu.2020.565236 PMID:33193333","DOI":"10.3389\/fimmu.2020.565236"},{"key":"5223","doi-asserted-by":"crossref","unstructured":"Aljurf M, Snowden JA, Hayden P, Orchard KH, McGrath E. Quality management and accreditation in hematopoietic stem cell transplantation and cellular therapy. The JACIE Guide. https:\/\/www.ebmt.org\/sites\/default\/files\/2021-03\/The-JACIE-Guide.pdf. Accessed June 9, 2021.","DOI":"10.1007\/978-3-030-64492-5"},{"key":"5224","unstructured":"Tarhan A, Turetken O, van den Biggelaar FJHM. Assessing healthcare process maturity: challenges of using a business process maturity model. Proceedings of the 9th International Conference on Pervasive Computing Technologies for Healthcare 2015; 344-347. Online https:\/\/dl.acm.org\/doi\/10.5555\/2826165.2826233. Accessed June 9, 2021."},{"key":"5225","unstructured":"De Bruin T, Rosemann M, Freeze R, Kulkarni U. Understanding the main phases of developing a maturity assessment model. ACIS 2005 Proceedings. Sydney, NSW, Australia"},{"key":"5226","unstructured":"th Australasian Conference on Information Systems 2005; 8-19."},{"key":"5227","unstructured":"Fisher, DM. The Business Process Maturity Model. A practical approach for identifying opportunities for optimization. BPTrends 2004. https:\/\/www.bptrends.com\/bpt\/wp-content\/publicationfiles\/10-04ARTBPMaturityModel-Fisher.pdf. Accessed June 9, 2021."},{"key":"5228","doi-asserted-by":"crossref","unstructured":"Mettler T, Rohner P, Winter R. Towards a classification of maturity models in information systems. In D\u2019Atri A, De Marco M, Braccini AM, Cabiddu F (Eds), Management of the interconnected world (pp. 333-340). Springer-Verlag Berlin Heidelberg 2010. https:\/\/doi.org\/10.1007\/978-3-7908-2404-9_39","DOI":"10.1007\/978-3-7908-2404-9_39"},{"key":"5229","doi-asserted-by":"crossref","unstructured":"R\u00f6glinger M, P\u00f6ppelbu\u00df J, Becker J. Maturity models in business process management. Bus Process Manag J. 2012;18(2):328-346. https:\/\/doi.org\/10.1108\/14637151211225225","DOI":"10.1108\/14637151211225225"},{"key":"5230","doi-asserted-by":"crossref","unstructured":"Iversen J, Nielsen PA, Norbjerg J. Situated assessment of problems in software development. ACM SIGMIS Database. 1999;30(2):66-81. https:\/\/doi.org\/10.1145\/383371.383376","DOI":"10.1145\/383371.383376"},{"key":"5231","unstructured":"Locatelli P, Cirilli F, Panno E, Provenzano S, Sanfilippo R, Casali P. Digital Support for Hub-and-Spoke Disease Network. Proceedings of the 12th IADIS International Conference e-Health 2020, EH 2020 - Part of the 14th Multi Conference on Computer Science and Information Systems, MCCSIS 2020; 2020: 198-202."},{"key":"5232","doi-asserted-by":"crossref","unstructured":"Bitter J, van Veen-Berkx E, Gooszen G, van Amelsvoort P. Multidisciplinary teamwork is an important issue to healthcare professionals. Team Perform Manage. 2013;19(5\/6):263-278. https:\/\/doi.org\/10.1108\/TPM-11-2012-0041","DOI":"10.1108\/TPM-11-2012-0041"},{"key":"5233","doi-asserted-by":"crossref","unstructured":"Grassi MO, Furino C, Recchimurzo N, et al. Implementation of Lean healthcare methodology in designing an Intravitreal Injection Center: first Italian experience. Int Ophthalmol. 2020;40(10):2607-2615. https:\/\/doi.org\/10.1007\/s10792-020-01441-1 PMID:32514665","DOI":"10.1007\/s10792-020-01441-1"},{"key":"5234","unstructured":"Locatelli P, Restifo N, Gastaldi L, Sini E, Torresani M. The evolution of hospital information systems and the role of electronic patient records: from the Italian scenario to a real case. Stud Health Technol Inform. 2010;160(Pt 1):247-251. PMID:20841687"},{"key":"5235","unstructured":"Wood JC, Wood MC. W. E. Deming: Critical evaluation in business and management. Routledge 2005; 2: 87-107."},{"key":"5236","doi-asserted-by":"crossref","unstructured":"Avitabile T, Boscia F, Dell\u2019Erba A, et al. Definition of indicators of appropriateness in the management of neovascular age-related macular degeneration: an expert opinion. Eur J Ophthalmol. 2020;30(4):795-804. https:\/\/doi.org\/10.1177\/1120672120915685 PMID:32389030","DOI":"10.1177\/1120672120915685"},{"key":"5237","doi-asserted-by":"crossref","unstructured":"Locatelli P, Facchini R, Moser R et al. Effectively introducing mobile solutions in hospitals: the importance of process perspective and KPIs. Proceedings of the IEEE 27th International Symposium on Computer-Based Medical Systems 2014; 417-420. https:\/\/doi.org\/10.1109\/CBMS.2014.45","DOI":"10.1109\/CBMS.2014.45"}],"container-title":["Global &amp; Regional Health Technology Assessment"],"original-title":[],"link":[{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/download\/2340\/2520","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/download\/2340\/2521","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/download\/2340\/2522","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/download\/2340\/2520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T10:43:20Z","timestamp":1641811400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/view\/2340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.33393\/grhta.2022.2340","relation":{},"ISSN":["2283-5733","2284-2403"],"issn-type":[{"type":"electronic","value":"2283-5733"},{"type":"print","value":"2284-2403"}],"subject":[],"published":{"date-parts":[[2022,1,8]]}}}